miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells

56Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

It has been previously reported that the deregulation of microRNAs in gastric cancer (GC) was correlated with the progression and prognosis. miR-429, a member of the miR-200 family, was previously shown to play an important role in human carcinomas. Our study shows that miR-429 is significantly downregulated in GC tissues compared with matched nontumor tissues. Overexpression of miR-429 in GC cells suppressed cell proliferation. Fascin-1 (FSCN1) was identified as one of the targets of miR-429 and knockdown of FSCN1 mimics the function of miR-429 overexpression. In conclusion, miR-429 acts as a tumor suppressor by targeting FSCN1, suggesting that miR-429 and FSCN1 can both be potential therapeutic targets of GC.

Cite

CITATION STYLE

APA

Zhang, M., Dong, B. B., Lu, M., Zheng, M. J., Chen, H., Ding, J. Z., … Xu, Y. H. (2016). miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells. OncoTargets and Therapy, 9, 1123–1133. https://doi.org/10.2147/OTT.S91879

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free